Sreeji Gopinathan joins Lupin as Chief Information Officer
Mumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will lead the IT function for Lupin globally, based in Mumbai.
Sreeji brings to Lupin over 20 years of significant domain expertise and global experience. Most recently, Sreeji was with Reckitt Benckiser. Prior to that, he was associated with Philips, Procter & Gamble, ISRO and Asea Brown Boveri. Sreeji holds a Master's degree in Business Administration from the University of Edinburgh, UK and B. Tech (Applied Electronics and Instrumentation) from the University of Kerala.
Also read:-Lupin clears Japanese regulator PMDA inspection of Goa facility
Commenting on the appointment, Nilesh Gupta – Managing Director, Lupin said, "We have built a very solid Information Technology foundation, whether it pertains to our manufacturing operations, our sales operations or our HR processes. With Sreeji's joining, Lupin's IT function will be further strengthened. With his substantial experience and ability to closely work with businesses, he will expand and invigorate our initiatives in digitization, process automation, data management and analytics which will eventually help improve business results."
Also read:- Lupin unveils generic version of Viagra in US
Lupin is the 8th largest generics pharmaceutical company by revenues (31st Mar 2019, Bloomberg LTM) respectively. The Company is the 3rd largest pharmaceutical player in the US by prescriptions (IQVIA MAT Jun 2019); 3 rd largest Indian pharmaceutical company by global revenues (31st Mar 2019, Bloomberg LTM); 5th largest generic pharmaceutical player in Japan and 6th largest company in the Indian Pharmaceutical Market (IQVIA MAT Jun 2019).
Sreeji brings to Lupin over 20 years of significant domain expertise and global experience. Most recently, Sreeji was with Reckitt Benckiser. Prior to that, he was associated with Philips, Procter & Gamble, ISRO and Asea Brown Boveri. Sreeji holds a Master's degree in Business Administration from the University of Edinburgh, UK and B. Tech (Applied Electronics and Instrumentation) from the University of Kerala.
Also read:-Lupin clears Japanese regulator PMDA inspection of Goa facility
Commenting on the appointment, Nilesh Gupta – Managing Director, Lupin said, "We have built a very solid Information Technology foundation, whether it pertains to our manufacturing operations, our sales operations or our HR processes. With Sreeji's joining, Lupin's IT function will be further strengthened. With his substantial experience and ability to closely work with businesses, he will expand and invigorate our initiatives in digitization, process automation, data management and analytics which will eventually help improve business results."
Also read:- Lupin unveils generic version of Viagra in US
Lupin is the 8th largest generics pharmaceutical company by revenues (31st Mar 2019, Bloomberg LTM) respectively. The Company is the 3rd largest pharmaceutical player in the US by prescriptions (IQVIA MAT Jun 2019); 3 rd largest Indian pharmaceutical company by global revenues (31st Mar 2019, Bloomberg LTM); 5th largest generic pharmaceutical player in Japan and 6th largest company in the Indian Pharmaceutical Market (IQVIA MAT Jun 2019).
Asea Brown BoveriChief Information OfficerCIOGambleISROLupinLupin Managing DirectorNew DelhiNilesh GuptapharmaPharma major Lupin LtdPhilipsProcterReckitt BenckiserSreeji Gopinathan
Source : PTIMedical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd